Relmada Therapeutics, Inc. — Form D
Relmada Therapeutics, Inc. of BLUE BELL, PA, a company, filed a Form D exempt-offering notice with the SEC on 2014-05-22. The offering totals $15.1M, of which $15.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2014-05-22
- Form: D
- Accession: 0001213900-14-003729
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $15.1M
- Amount sold: $15.1M
- Minimum investment: $100K
- Investors: 225
- Date of first sale: 2014-05-12
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-217828
Issuer
- Name: Relmada Therapeutics, Inc.
- CIK: 0001554535
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 146 MEDINAH DRIVE, BLUE BELL, PA, 19422
- Phone: 610-272-2071
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Shreeram O Agharkar | Director | NEW YORK, NY |
| Sandesh O Seth | Director | NEW YORK, NY |
| Sergio Traversa | Director | Blue Bell, PA |
| Nabil M Yazgi | Director | NEW YORK, NY |
| Douglas O Beck | Executive Officer | NEW YORK, NY |
| Eliseo O Salinas | Executive Officer | NEW YORK, NY |
| Sergio Traversa | Executive Officer | Blue Bell, PA |
| Sandesh Seth | Director | NEW YORK, NY |
| Najib Babul | Director | Blue Bell, PA |
| Najib Babul | Executive Officer | Blue Bell, PA |
Other filings by this issuer (3)
More